Global Clinical Trials Market Report By Phase (Phase I, Phase II, Phase III And Phase IV), Study Design (Interventional, Observational And Expanded Access), Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity And Cardiovascular) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210536
February 2020
Report Formats:

As per this study the Global Clinical Trials Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.

The clinical trials are the research investigation that finds new ways to prevent, diagnose or treat disease. It’s the final step in a long process. Where new drugs, new approaches to surgery or radiation therapy, and advances in new areas such as gene therapy is investigated. Testing of treatment or drug is done in steps called phases.
 
Market Dynamics
 
The growing prevalence of diseases along with the rising incidence of new diseases is driving market growth. Also, increasing investments on new product development, such as personalized medicine and evolution in technology in emerging countries is fuelling market growth. However, budget constraints of small and medium-sized pharmaceutical and biotechnology companies are expected to restrain the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of clinical trials.
 
Market Segmentation
 
The broad clinical trials market has been sub-grouped into phase, study design and indication. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV
 
By Study Design
  • Interventional
  • Observational
  • Expanded Access
 
By Indication
  • Autoimmune/Inflammation
  • Pain Management
  • Oncology
  • CNS Condition
  • Diabetes
  • Obesity
  • Cardiovascular
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for clinical trials in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Clinical Trials Market By Revenue (USD MN)


 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the clinical trials market include Charles River Laboratories, ICON plc, Paraxel International Corporation, Quintiles IMS, SGS SA, and others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Clinical Trials  Market
       2.2. Global Clinical Trials  Market Snapshot
 
3 . CLINICAL TRIALS  – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Clinical Trials  Market
       3.3. Market Restraints of Clinical Trials  Market
       3.4. Opportunities of Clinical Trials  Market
       3.5. Trends of Clinical Trials  Market
       3.6. Porter’s Five Force Analysis of Clinical Trials  Market
       3.7. Clinical Trials  Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Phase
           3.7.2 Market Attractive Analysis by Study Design
           3.7.3 Market Attractive Analysis by Indication
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Clinical Trials  Value Chain Analysis
       4.2. Clinical Trials  Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Clinical Trials  Raw Material Manufactures List
           4.2.3. Price Trend of Clinical Trials  Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL CLINICAL TRIALS  MARKET ANALYSIS BY PHASE
       5.1 Overview by Phase
       5.2 Global Clinical Trials  Market Analysis by Phase
       5.3 Market Analysis of Phase I by Regions
       5.4 Market Analysis of Phase II by Regions
       5.5 Market Analysis of Phase III by Regions
       5.6 Market Analysis of Phase IV by Regions
 
6 . GLOBAL CLINICAL TRIALS  MARKET ANALYSIS BY STUDY DESIGN
       6.1 Overview by Study Design
       6.2 Global Clinical Trials  Market Analysis by Study Design
       6.3 Market Analysis of Interventional by Regions
       6.4 Market Analysis of Observational by Regions
       6.5 Market Analysis of Expanded Access by Regions
 
7 . GLOBAL CLINICAL TRIALS  MARKET ANALYSIS BY INDICATION
       7.1 Overview by Indication
       7.2 Global Clinical Trials  Market Analysis by Indication
       7.3 Market Analysis of Autoimmune/Inflammation by Regions
       7.4 Market Analysis of Pain Management by Regions
       7.5 Market Analysis of Oncology by Regions
       7.6 Market Analysis of CNS Condition by Regions
       7.7 Market Analysis of Diabetes by Regions
       7.8 Market Analysis of Obesity by Regions
       7.9 Market Analysis of Cardiovascular by Regions
 
8 . GLOBAL CLINICAL TRIALS  MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Clinical Trials  Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Clinical Trials  Market Estimate by Market Segment
           8.4.3. Europe Clinical Trials  Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Clinical Trials  Market Estimate by Market Segment
           8.5.3. Asia Pacific Clinical Trials  Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Clinical Trials  Market Estimate by Market Segment
           8.6.3. Latin America Clinical Trials  Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Clinical Trials  Market Estimate by Market Segment
           8.7.3. Middle East & Africa Clinical Trials  Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIALS  COMPANIES
       9.1. Clinical Trials  Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF CLINICAL TRIALS  INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Charles River Laboratories
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. ICON plc
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Paraxel International Corporation
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Quintiles IMS
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. SGS SA
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Others
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
 
11.  IMPACT ANALYSIS OF COVID-19 OUTBREAK
       11.1. Impact Analysis of Covid-19 Outbreak on the Market
           11.1.1. Direct Impact on Production
           11.1.2. Supply Chain and Market Disruption
           11.1.3. Financial Impact on Firms and Financial Markets
       11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       11.3. Pre V/S Post COVID-19 Market
       11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
       11.5. COVID-19: Micro and Macro Factor Analysis on the Market
    
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers 
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Clinical Trials  Market Analysis by Phase (USD MN)
  • Global Clinical Trials  Market Analysis in Phase I by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Phase II by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Phase III by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Phase IV by Geography (USD MN)
  • Global Clinical Trials  Market Analysis by Study Design (USD MN)
  • Global Clinical Trials  Market Analysis in Interventional by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Observational by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Expanded Access by Geography (USD MN)
  • Global Clinical Trials  Market Analysis by Indication (USD MN)
  • Global Clinical Trials  Market Analysis in Autoimmune/Inflammation by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Pain Management by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Oncology by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in CNS Condition by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Diabetes by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Obesity by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Cardiovascular by Geography (USD MN)
  • Global Clinical Trials  Market by Geography (USD MN)
  • North America Clinical Trials  Market Analysis by Phase (USD MN)
  • North America Clinical Trials  Market Estimate by Study Design (USD MN)
  • North America Clinical Trials  Market Estimate by Indication (USD MN)
  • North America Clinical Trials  Market Estimate by Country (USD MN)
  • United State Clinical Trials  Market Analysis by Phase (USD MN)
  • United State Clinical Trials  Market Estimate by Study Design (USD MN)
  • United State Clinical Trials  Market Analysis by Indication (USD MN)
  • Rest of North America Clinical Trials  Market Analysis by Phase (USD MN)
  • Rest of North America Clinical Trials  Market Estimate by Study Design (USD MN)
  • Rest of North America Clinical Trials  Market Estimate by Indication(USD MN)
  • Europe Clinical Trials  Market Analysis by Phase (USD MN)
  • Europe Clinical Trials  Market Estimate by Study Design (USD MN)
  • Europe Clinical Trials  Market Estimate by Indication (USD MN)
  • United Kingdom Clinical Trials  Market Analysis by Phase (USD MN)
  • United Kingdom Clinical Trials  Market Estimate by Study Design (USD MN)
  • United Kingdom Clinical Trials  Market Estimate by Indication (USD MN)
  • France Clinical Trials  Market Analysis by Phase (USD MN)
  • France Clinical Trials  Market Estimate by Study Design (USD MN)
  • France Clinical Trials  Market Estimate by Indication (USD MN)
  • Germany Clinical Trials  Market Analysis by Phase (USD MN)
  • Germany Clinical Trials  Market Estimate by Study Design (USD MN)
  • Germany Clinical Trials  Market Estimate by Indication (USD MN)
  • Rest of Europe Clinical Trials  Market Analysis by Phase (USD MN)
  • Rest of Europe Clinical Trials  Market Estimate by Study Design (USD MN)
  • Rest of Europe Clinical Trials  Market Estimate by Indication (USD MN)
  • Asia Pacific Clinical Trials  Market Analysis by Phase (USD MN)
  • Asia Pacific Clinical Trials  Market Estimate by Study Design (USD MN)
  • Asia Pacific Clinical Trials  Market Estimate by Indication (USD MN)
  • Asia Pacific Clinical Trials  Market Estimate by Country (USD MN)
  • China Clinical Trials  Market Analysis by Phase (USD MN)
  • China Clinical Trials  Market Estimate by Study Design (USD MN)
  • China Clinical Trials  Market Estimate by Indication (USD MN)
  • Japan Clinical Trials  Market Analysis by Phase (USD MN)
  • Japan Clinical Trials  Market Estimate by Study Design (USD MN)
  • Japan Clinical Trials  Market Estimate by Indication (USD MN)
  • India Clinical Trials  Market Analysis by Phase (USD MN)
  • India Clinical Trials  Market Estimate by Study Design (USD MN)
  • India Clinical Trials  Market Estimate by Indication (USD MN)
  • Rest of Asia Pacific Clinical Trials  Market Analysis by Phase (USD MN)
  • Rest of Asia Pacific Clinical Trials  Market Estimate by Study Design (USD MN)
  • Rest of Asia Pacific Clinical Trials  Market Estimate by Indication (USD MN)
  • Latin America Clinical Trials  Market Analysis by Phase (USD MN)
  • Latin America Clinical Trials  Market Estimate by Study Design (USD MN)
  • Latin America Clinical Trials  Market Estimate by Indication (USD MN)
  • Latin America Clinical Trials  Market Estimate by Country (USD MN)
  • Brazil Clinical Trials  Market Analysis by Phase (USD MN)
  • Brazil Clinical Trials  Market Estimate by Study Design (USD MN)
  • Brazil Clinical Trials  Market Estimate by Indication (USD MN)
  • Rest of Latin America Clinical Trials  Market Analysis by Phase (USD MN)
  • Rest of Latin America Clinical Trials  Market Estimate by Study Design (USD MN)
  • Rest of Latin America Clinical Trials  Market Estimate by Indication (USD MN)
  • Middle East & Africa Clinical Trials  Market Analysis by Phase (USD MN)
  • Middle East & Africa Clinical Trials  Market Estimate by Study Design (USD MN)
  • Middle East & Africa Clinical Trials  Market Estimate by Indication (USD MN)
  • Middle East & Africa Clinical Trials  Market Estimate by Country (USD MN)
  • Middle East Clinical Trials  Market Analysis by Phase (USD MN)
  • Middle East Clinical Trials  Market Estimate by Study Design (USD MN)
  • Middle East Clinical Trials  Market Estimate by Indication (USD MN)
  • Africa Clinical Trials  Market Analysis by Phase (USD MN)
  • Africa Clinical Trials  Market Estimate by Study Design (USD MN)
  • Africa Clinical Trials  Market Estimate by Indication (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Clinical Trials  Report
  • Market Research Process
  • Market Research Methodology
  • Global Clinical Trials  Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Phase
  • Market Attractiveness Analysis by Study Design
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Clinical Trials  Market Analysis by Phase (USD MN)
  • Global Clinical Trials  Market Analysis in Phase I by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Phase II by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Phase III by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Phase IV by Geography (USD MN)
  • Global Clinical Trials  Market Analysis by Study Design (USD MN)
  • Global Clinical Trials  Market Analysis in Interventional by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Observational by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Expanded Access by Geography (USD MN)
  • Global Clinical Trials  Market Analysis by Indication (USD MN)
  • Global Clinical Trials  Market Analysis in Autoimmune/Inflammation by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Pain Management by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Oncology by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in CNS Condition by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Diabetes by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Obesity by Geography (USD MN)
  • Global Clinical Trials  Market Analysis in Cardiovascular by Geography (USD MN)
  • Latin America Clinical Trials  Market by Revenue
  • Middle East & Africa Clinical Trials  Market by Revenue
  • Recent Development in Clinical Trials  Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials